Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
276 | Pharmaceutical Technology in Hospital Pharmacy | journal | 0.211 Q3 | 1 | 0 | 2 | 0 | 4 | 2 | 0.00 | 0.00 | |
275 | Frontiers in Clinical Drug Research - HIV | book series | 0.111 Q4 | 1 | 0 | 6 | 0 | 1 | 3 | 0.17 | 0.00 | |
274 | Anti-Obesity Drug Discovery and Development | book series | 0.133 Q4 | 1 | 0 | 7 | 0 | 0 | 1 | 0.00 | 0.00 | |
273 | Synergy | journal | 0.354 Q3 | 15 | 0 | 9 | 0 | 24 | 9 | 0.00 | 0.00 | |
272 | Circular Farmaceutica | journal | 0.103 Q4 | 3 | 0 | 11 | 0 | 0 | 10 | 0.00 | 0.00 | |
271 | Frontiers in Clinical Drug Research - Anti Allergy Agents | book series | 0.111 Q4 | 1 | 0 | 12 | 0 | 1 | 3 | 0.00 | 0.00 | |
270 | Open Access Journal of Clinical Trials | journal | 0.561 Q2 | 15 | 1 | 15 | 54 | 31 | 14 | 1.11 | 54.00 | |
269 | Oral Therapeutics and Pharmacology | journal | 0.102 Q4 | 6 | 5 | 16 | 98 | 1 | 16 | 0.00 | 19.60 | |
268 | Frontiers in Clinical Drug Research - CNS and Neurological Disorders | book series | 0.133 Q4 | 1 | 1 | 17 | 0 | 3 | 1 | 0.33 | 0.00 | |
267 | Adverse Drug Reaction Bulletin | journal | 0.126 Q4 | 8 | 6 | 18 | 196 | 5 | 18 | 0.17 | 32.67 | |
266 | Cancer Innovation | journal | 0.389 Q3 | 4 | 56 | 20 | 3056 | 23 | 19 | 1.15 | 54.57 | |
265 | Frontiers in Clinical Drug Research - Anti Infectives | book series | 0.104 Q4 | 2 | 0 | 20 | 0 | 1 | 9 | 0.00 | 0.00 | |
264 | Drug Target Insights | journal | 0.429 Q3 | 16 | 16 | 23 | 617 | 52 | 22 | 2.28 | 38.56 | |
263 | Drug Metabolism Letters | journal | 0.175 Q4 | 31 | 0 | 24 | 0 | 25 | 23 | 1.04 | 0.00 | |
262 | WHO Drug Information | journal | 0.102 Q4 | 11 | 5 | 26 | 15 | 1 | 20 | 0.06 | 3.00 | |
261 | Journal fur Pharmakologie und Therapie | journal | 0.103 Q4 | 2 | 0 | 27 | 0 | 0 | 12 | 0.00 | 0.00 | |
260 | Cancer and Chemotherapy Reviews | journal | 0.105 Q4 | 4 | 0 | 30 | 0 | 1 | 27 | 0.00 | 0.00 | |
259 | Journal of Health Policy and Outcomes Research | journal | 0.111 Q4 | 1 | 12 | 32 | 326 | 3 | 32 | 0.13 | 27.17 | |
258 | Topics in antiviral medicine | journal | 0.614 Q2 | 46 | 18 | 36 | 403 | 63 | 36 | 1.89 | 22.39 | |
257 | Current Topics in Pharmacology | journal | 0.144 Q4 | 8 | 0 | 37 | 0 | 18 | 36 | 0.70 | 0.00 | |
256 | Journal of International Peacekeeping | journal | 0.216 Q3 | 14 | 24 | 40 | 1699 | 29 | 38 | 0.87 | 70.79 | |
255 | Therapeutic Advances in Cardiovascular Disease | journal | 0.553 Q2 | 41 | 17 | 40 | 1230 | 95 | 37 | 2.48 | 72.35 | |
254 | Medical Cannabis and Cannabinoids | journal | 0.731 Q2 | 13 | 19 | 41 | 621 | 168 | 34 | 3.65 | 32.68 | |
253 | Recent advances in inflammation & allergy drug discovery | journal | 0.443 Q3 | 37 | 19 | 42 | 1111 | 84 | 35 | 0.86 | 58.47 | |
252 | Journal of Psychedelic Studies | journal | 0.503 Q3 | 12 | 37 | 43 | 1858 | 116 | 43 | 2.68 | 50.22 | |
251 | Epitheorese Klinikes Farmakologias kai Farmakokinetikes | journal | 0.138 Q4 | 5 | 17 | 46 | 385 | 3 | 45 | 0.00 | 22.65 | |
250 | Japanese Pharmacology and Therapeutics | journal | 0.120 Q4 | 18 | 2 | 46 | 1 | 7 | 44 | 0.00 | 0.50 | |
249 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 0.726 Q2 | 13 | 18 | 47 | 751 | 163 | 41 | 3.74 | 41.72 | |
248 | International Journal of Breast Cancer | journal | 0.443 Q3 | 23 | 7 | 48 | 302 | 93 | 48 | 1.76 | 43.14 | |
247 | HIV Research and Clinical Practice | journal | 0.616 Q2 | 54 | 14 | 52 | 571 | 97 | 52 | 2.15 | 40.79 | |
246 | Recent Advances in Anti-Infective Drug Discovery | journal | 0.203 Q3 | 38 | 18 | 53 | 861 | 58 | 50 | 1.07 | 47.83 | |
245 | Trends in Immunotherapy | journal | 0.133 Q4 | 4 | 28 | 54 | 1817 | 14 | 51 | 0.24 | 64.89 | |
244 | Review of Clinical Pharmacology and Pharmacokinetics, International Edition | journal | 0.150 Q4 | 9 | 16 | 58 | 437 | 5 | 46 | 0.11 | 27.31 | |
243 | Giornale Italiano di Farmacia Clinica | journal | 0.158 Q4 | 8 | 21 | 60 | 507 | 5 | 51 | 0.15 | 24.14 | |
242 | Japanese Journal of Chemotherapy | journal | 0.108 Q4 | 13 | 0 | 62 | 0 | 7 | 62 | 0.08 | 0.00 | |
241 | Clinical Pharmacology: Advances and Applications | journal | 0.695 Q2 | 34 | 11 | 64 | 701 | 156 | 59 | 3.17 | 63.73 | |
240 | Biomedical and Biopharmaceutical Research | journal | 0.133 Q4 | 4 | 18 | 66 | 651 | 21 | 62 | 0.15 | 36.17 | |
239 | Health Biotechnology and Biopharma | journal | 0.173 Q4 | 3 | 20 | 66 | 750 | 36 | 66 | 0.61 | 37.50 | |
238 | Translational and Clinical Pharmacology | journal | 0.303 Q3 | 12 | 21 | 66 | 522 | 71 | 63 | 1.13 | 24.86 | |
237 | ADMET and DMPK | journal | 0.533 Q3 | 21 | 39 | 67 | 2624 | 225 | 64 | 3.36 | 67.28 | |
236 | Geneesmiddelenbulletin | journal | 0.158 Q4 | 7 | 17 | 68 | 307 | 5 | 68 | 0.07 | 18.06 | |
235 | Medicine in Drug Discovery | journal | 0.815 Q2 | 16 | 20 | 68 | 1878 | 328 | 65 | 4.83 | 93.90 | |
234 | PPAR Research | journal | 0.698 Q2 | 59 | 15 | 69 | 877 | 199 | 69 | 3.25 | 58.47 | |
233 | Biologics: Targets and Therapy | journal | 1.276 Q1 | 47 | 17 | 70 | 681 | 364 | 70 | 5.81 | 40.06 | |
232 | Journal of Nephropharmacology | journal | 0.169 Q4 | 7 | 32 | 71 | 699 | 42 | 70 | 0.76 | 21.84 | |
231 | Current Cardiovascular Risk Reports | journal | 0.491 Q3 | 34 | 21 | 72 | 1537 | 119 | 72 | 1.94 | 73.19 | |
230 | OpenNano | journal | 0.824 Q2 | 21 | 80 | 73 | 7983 | 473 | 73 | 6.48 | 99.79 | |
229 | Drug Resistance Updates | journal | 4.665 Q1 | 132 | 74 | 76 | 6493 | 1477 | 75 | 17.53 | 87.74 | |
228 | Drug Metabolism Reviews | journal | 0.870 Q2 | 108 | 20 | 78 | 2451 | 403 | 78 | 3.73 | 122.55 | |
227 | Journal de Pharmacie Clinique | journal | 0.112 Q4 | 16 | 23 | 78 | 377 | 9 | 65 | 0.13 | 16.39 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®